Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy

Conditions

• Prostate Cancer

Interventions

• DRUG: 0.02 mg/kg of DGPR1008 Injection was administered 24 hours before surgery
• DRUG: 0.04 mg/kg of DGPR1008 Injection was administered 24 hours before surgery
• DRUG: 0.06 mg/kg of DGPR1008 Injection was administered 24 hours before surgery

Sponsor

Zhu Yinjie